Our client is a digital healthcare company with a diagnostic-as-a-service solution that enables FDA-authorized self-testing and real-time outbreak monitoring. Currently, the solution is fit for the US and a couple of Asian markets.
The company has recently expanded its offering from solely catering to corporations to providing rapid individual home self-testing for people. Corporate clients use the DaaS solution for identifying and tracing COVID-19 outbursts and minimizing expenses caused by hospitalization, shutdowns, and absenteeism. As of now, the company operates web and mobile applications that run on AI technologies.